Immunomedics, Inc. (NASDAQ:IMMU)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

IMMU News and Commentary

Caps

How do you think IMMU will perform against the market?

Add Stock to CAPS Watchlist

All Players

226 Outperform
22 Underperform
 

All-Star Players

34 Outperform
4 Underperform
 

Wall Street

7 Outperform
1 Underperform
 

Top IMMU Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SaintCroix (99.29)
Submitted December 15, 2017

There are no drugs for triple negative breast cancer. IMMU has one, and it did so well in it's phase 2 trial, the FDA is fast-tracking the drug and it will be submitted in first quarter 2018. It's a multi-billion dollar market and IMMU's drug is far… More

zzlangerhans (99.56)
Submitted November 24, 2016

Surprisingly, my recent long bet on Immunomedics turned out to be a winner. Perhaps I have Trump to thank for that since I bought in shortly before the election surprise. Or perhaps I just got lucky: I've made a dozen bottom feeding picks in the last… More

IMMU VS S&P 500 (SPY)

Fools bullish on IMMU are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about IMMU.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 6/9/2018 5:20:02 PM : Outperform Start Price: $24.19 IMMU Score: +5.68

covered by analysts at B. Riley on Thursday. They set a "buy" rating and a $53.00 price target on the stock. 119.4% upside from the current price of $24.16

Recs

1
Member Avatar SaintCroix (99.29) Submitted: 12/14/2017 9:45:58 PM : Outperform Start Price: $12.58 IMMU Score: +97.60

There are no drugs for triple negative breast cancer. IMMU has one, and it did so well in it's phase 2 trial, the FDA is fast-tracking the drug and it will be submitted in first quarter 2018. It's a multi-billion dollar market and IMMU's drug is far more effective than existing therapies. Pretty much a lock, I think. We will see!

Recs

0
Member Avatar tj726 (57.04) Submitted: 10/29/2017 5:13:08 PM : Outperform Start Price: $11.67 IMMU Score: +109.87

success of new drug, new board, buyout/partner potential

Leaderboard

Find the members with the highest scoring picks in IMMU.

Score Leader

GyroDynasty

GyroDynasty (< 20) Score: +1,481.47

The Score Leader is the player with the highest score across all their picks in IMMU.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
GyroDynasty < 20 9/29/2015 Outperform 5Y $1.57 +1,514.65% +46.58% +1,468.07 0 Comment
2st2 93.98 1/8/2009 Outperform NS $1.75 +1,348.57% +211.62% +1,136.96 0 Comment
2st4 97.93 1/8/2009 Outperform NS $1.75 +1,348.57% +212.08% +1,136.49 0 Comment
bibbes 35.49 8/3/2015 Outperform 5Y $2.05 +1,136.59% +31.13% +1,105.46 0 Comment
pavlos1971 98.73 8/3/2015 Outperform 5Y $2.05 +1,136.59% +31.13% +1,105.46 0 Comment
wmtworker 78.01 8/3/2015 Outperform 5Y $2.05 +1,136.59% +31.13% +1,105.46 0 Comment
hmcnamee < 20 5/12/2009 Outperform 1Y $1.81 +1,300.55% +204.32% +1,096.23 1 Comment
mikolabruce 49.55 10/10/2006 Outperform 3M $2.00 +1,167.50% +116.80% +1,050.70 0 Comment
DGGO999 40.91 11/26/2007 Outperform 1Y $2.07 +1,124.64% +100.19% +1,024.44 0 Comment
beemer330 71.66 7/14/2016 Outperform 1Y $2.21 +1,047.06% +27.63% +1,019.42 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackchardan 62.11 1/8/2014 Outperform NS $5.02 +404.98% +50.43% +354.55 0 Comment
TrackJimCramer 85.46 8/15/2013 Underperform 3W $5.11 +396.09% +65.87% -330.22 0 Comment
TrackUltraLong < 20 1/23/2013 Outperform NS $2.91 +771.13% +85.05% +686.08 1 Comment
tracksummerstree 89.30 8/31/2011 Outperform NS $4.00 +533.75% +125.36% +408.39 0 Comment
TrackOppenheimer 76.20 5/17/2011 Outperform NS $3.77 +572.41% +107.98% +464.43 0 Comment
TrackWedbush 88.98 2/23/2011 Outperform NS $3.36 +654.46% +110.68% +543.78 0 Comment
TrackJGreenblatt 60.36 2/16/2010 Outperform 1Y $3.05 +21.31% +22.15% -0.84 2/28/2011 @ $3.70 1 Comment
TrackBreanMurray 79.10 7/3/2007 Outperform NS $4.32 +486.81% +90.89% +395.91 0 Comment
TrackLazardCapit 84.67 2/20/2007 Outperform NS $4.76 +432.56% +101.47% +331.09 0 Comment

Featured Broker Partners


Advertisement